Worldwide CAR-T Cell Therapy Industry - Featuring Aleta BioTherapeutics, Atara Biotherapeutics and BioNTech Among Others
Share this article Share this article ResearchAndMarkets.coms offering. CAR-T cell therapy is a remarkably promising treatment for cancer patients. It is a type of immunotherapy where doctors collect immune cells, modify them in a laboratory, and provide them the power to easily recognize and kill cancer cells. When infused into a patient, the cells get multiplied and stay in the body as "living drugs." T-cells form the backbone of CAR-T cell therapy. T-cells are the workhorses of our immune sy...
Oxford Biomedica Tecartus Brexucabtagene Aleta Biotherapeutics Yescarta Axicabtagene Bristol Myers Squibb Laura Wood
Source: prnewswire.com